Prothix LifeSciences forms Strategic Alliance with Oviya MedSafe to Advance Healthcare Solutions

MUMBAI, India - Dec. 23, 2024 - PRLog -- Prothix LifeSciences, a leading global CRO and Oviya MedSafe, a global leader in pharmacovigilance consulting and drug safety services, have entered into a strategic partnership aiming to extend their complementary expertise and service offerings in pharmacovigilance, drug safety, regulatory compliance, clinical trials, and related drug development services to the global healthcare sector. This partnership, formalized through a MOU, will leverage the business synergies between the two organizations to deliver enhanced, integrated healthcare solutions across diverse global markets.

Fostering Growth in Pharmacovigilance and Clinical Trials Service Excellence

This partnership represents a significant milestone forward in the pursuit of comprehensive, high-quality services to meet the evolving needs of the global drug safety and clinical trials solutions. By combining industry expertise, resources, and capabilities, both companies create sustainable solutions addressing critical challenges in the delivery of these global services.

"Our alliance with Oviya MedSafe is an exciting step forward in our mission to enhance our value proposition as a full-service CRO," said Yogendra Kumar Choudhary, Managing Director & CEO of Prothix LifeSciences Pvt Ltd. "By merging our extensive expertise in drug development and clinical trials with Oviya MedSafe's global leadership in pharmacovigilance and drug safety services, we are poised to deliver impactful, future-ready solutions that prioritize safety, efficacy, and patient well-being worldwide."

Dr. J Vijay Venkatraman, Managing Director & CEO of Oviya MedSafe Pvt Ltd, echoed this sentiment: "Our strategic partnership with Prothix LifeSciences gives us immense scope to fortify our position as a global leader in providing niche pharmacovigilance services, with Prothix's prowess in clinical trials and drug development. Together, we will deliver a comprehensive, integrated suite of services aimed at enhancing product safety, ensuring regulatory compliance, and accelerating the development of innovative therapies globally."

About Prothix LifeSciences (https://www.prothixlifesciences.com)

Prothix LifeSciences is a global, full-service CRO dedicated to advancing drug development and clinical trials across multiple sectors including nutraceuticals, ingredients, herbal products, cosmetics, food, phyto-pharmaceuticals, early-stage biotech start-ups, medical devices and established pharmaceutical companies whereas its genesis company Ethix Pharma is an advanced knowledge transfer organization having agile solutions for complex research outcomes enabling life sciences and the healthcare industry to bridge the gap between R&D and commercial success since 2009.

About Oviya MedSafe (https://www.oviyamedsafe.com)

Oviya MedSafe is a global pharmacovigilance consulting and drug safety services company, incorporated in India in 2012 and in the UK in 2014. Leveraging over 100 years of collective expertise, Oviya MedSafe provides end-to-end pharmacovigilance solutions and regulatory-compliant drug safety support to pharmaceutical companies, MAHs, and emerging biotech firms worldwide. Oviya MedSafe combines dynamic leadership with extensive medical and regulatory expertise to ensure compliance and enhance patient safety globally.